PAXLOVID recall in Canada: Risk of serious adverse reactions
In plain language
This recall involves PAXLOVID (nirmatrelvir and ritonavir) co-packaged tablets sold in Canada. It's being recalled because of new safety information regarding dosing for kidney impairment, drug interactions, and English-only labels. Stop using the product and follow the return/repair steps in the official notice.
What to do
- Stop using the product immediately.
- Consult a healthcare professional for guidance.
- Refer to the Canadian Product Monograph for complete information.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
PAXLOVID (150 mg nirmatrelvir; 100 mg ritonavir) co-packaged tablets for oral use
Model: DIN: 02524031
Why this matters
Risk of serious adverse reactions due to drug interactions or incorrect dosing
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN: 02524031
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of serious adverse reactions due to drug interactions or incorrect dosing
What should consumers do?
Stop using the product immediately. Consult a healthcare professional for guidance. Refer to the Canadian Product Monograph for complete information.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of serious adverse reactions due to drug interactions or incorrect dosing
When was this product recalled?
This product was recalled on January 17, 2022.
Is the PAXLOVID brand affected by this recall?
Yes, PAXLOVID products are affected by this recall. This recall involves PAXLOVID (nirmatrelvir and ritonavir) co-packaged tablets sold in Canada. It's being recalled because of new safety information regarding dosing for kidney impairment, drug interactions, and English-only labels. Stop using the product and follow the return/repair steps in the official notice.